|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001721,
umls-concept:C0011900,
umls-concept:C0021051,
umls-concept:C0021079,
umls-concept:C0021080,
umls-concept:C0030705,
umls-concept:C0042776,
umls-concept:C0086418,
umls-concept:C0205473,
umls-concept:C0332307,
umls-concept:C0441889,
umls-concept:C2347947
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-1-23
|
|
pubmed:abstractText |
A total of 175 human immunodeficiency virus (HIV)-positive intravenous drug users (IDU) with CD4 cell counts of <200 cells/microl were matched with 175 HIV-positive IDU with CD4 cell counts of >500 cells/microl. Enzyme immunoassay (EIA) reactivity and human T-cell lymphotropic virus type 2 (HTLV-2) Western blot (WB) positivity were more frequently observed in subjects with CD4 cell counts of >500 cells/microl. Most of the subjects with low CD4 cell counts and EIA reactivity carried HTLV-2 infection (WB positive and/or PCR positive). No subjects with low CD4 cell counts and a lack of reactive EIA were PCR positive for HTLV-2. Therefore, a negative EIA result can confidently discharge HTLV-2 infection in HIV-infected patients with severe immunosuppression, whereas PCR should be performed for subjects with a reactive HTLV EIA which is not further confirmed by WB.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-10504129,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-10773057,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-10960518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-12853410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-14987538,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-1965126,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-7730441,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-7940659,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-8797688,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-9131332,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-9282819,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16426016-9801344
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1556-6811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
160-1
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16426016-Antigens, CD4,
pubmed-meshheading:16426016-Blotting, Western,
pubmed-meshheading:16426016-HIV Infections,
pubmed-meshheading:16426016-HTLV-II Infections,
pubmed-meshheading:16426016-Human T-lymphotropic virus 2,
pubmed-meshheading:16426016-Humans,
pubmed-meshheading:16426016-Immunoassay,
pubmed-meshheading:16426016-Immunocompetence,
pubmed-meshheading:16426016-Immunosuppression,
pubmed-meshheading:16426016-Polymerase Chain Reaction,
pubmed-meshheading:16426016-Predictive Value of Tests,
pubmed-meshheading:16426016-Reproducibility of Results,
pubmed-meshheading:16426016-Serologic Tests
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?
|
|
pubmed:affiliation |
Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
